Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
FASEB J
2018 Jan 01;321:208-219. doi: 10.1096/fj.201700309R.
Show Gene links
Show Anatomy links
Proline-dependent and basophilic kinases phosphorylate human TRPC6 at serine 14 to control channel activity through increased membrane expression.
Hagmann H, Mangold N, Rinschen MM, Koenig T, Kunzelmann K, Schermer B, Benzing T, Brinkkoetter PT.
???displayArticle.abstract???
Signaling via the transient receptor potential (TRP) ion channel C6 plays a pivotal role in hereditary and sporadic glomerular kidney disease. Several studies have identified gain-of-function mutations of TRPC6 and report induced expression and enhanced channel activity of TRPC6 in association with glomerular diseases. Interfering with TRPC6 activity may open novel therapeutic pathways. TRPC6 channel activity is controlled by protein expression and stability as well as intracellular trafficking. Identification of regulatory phosphorylation sites in TRPC6 and corresponding protein kinases is essential to understand the regulation of TRPC6 activity and may result in future therapeutic strategies. In this study, an unbiased phosphoproteomic screen of human TRPC6 identified several novel serine phosphorylation sites. The phosphorylation site at serine 14 of TRPC6 is embedded in a basophilic kinase motif that is highly conserved across species. We confirmed serine 14 as a target of MAPKs and proline-directed kinases like cyclin-dependent kinase 5 (Cdk5) in cell-based as well as in vitro kinase assays and quantitative phosphoproteomic analysis of TRPC6. Phosphorylation of TRPC6 at serine 14 enhances channel conductance by boosting membrane expression of TRPC6, whereas protein stability and multimerization of TRPC6 are not altered, making serine 14 phosphorylation a potential drug target to interfere with TRPC6 channel activity.-Hagmann, H., Mangold, N., Rinschen, M. M., Koenig, T., Kunzelmann, K., Schermer, B., Benzing, T., Brinkkoetter, P. T. Proline-dependent and basophilic kinases phosphorylate human TRPC6 at serine 14 to control channel activity through increased membrane expression.
Abramowitz,
Physiology and pathophysiology of canonical transient receptor potential channels.
2009, Pubmed
Abramowitz,
Physiology and pathophysiology of canonical transient receptor potential channels.
2009,
Pubmed Ambrus,
Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes.
2015,
Pubmed Bokemeyer,
Different activation of mitogen-activated protein kinases in experimental proliferative glomerulonephritis.
1998,
Pubmed Bousquet,
The serine 814 of TRPC6 is phosphorylated under unstimulated conditions.
2011,
Pubmed Bousquet,
Protein kinase C-dependent phosphorylation of transient receptor potential canonical 6 (TRPC6) on serine 448 causes channel inhibition.
2010,
Pubmed Brinkkoetter,
The role of the podocyte in albumin filtration.
2013,
Pubmed Brinkkoetter,
Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells.
2009,
Pubmed Brinkkoetter,
p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo.
2010,
Pubmed Chen,
GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway.
2016,
Pubmed Cox,
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.
2008,
Pubmed Cox,
Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.
2014,
Pubmed Dryer,
TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.
2010,
Pubmed Eckel,
TRPC6 enhances angiotensin II-induced albuminuria.
2011,
Pubmed Elger,
Podocytes and the development of segmental glomerulosclerosis.
1998,
Pubmed Heeringa,
A novel TRPC6 mutation that causes childhood FSGS.
2009,
Pubmed Hisatsune,
Regulation of TRPC6 channel activity by tyrosine phosphorylation.
2004,
Pubmed Huang,
Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
2017,
Pubmed Huber,
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels.
2006,
Pubmed Ilatovskaya,
TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
2015,
Pubmed Ilatovskaya,
Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels.
2015,
Pubmed Kanda,
Tyrosine phosphorylation-dependent activation of TRPC6 regulated by PLC-γ1 and nephrin: effect of mutations associated with focal segmental glomerulosclerosis.
2011,
Pubmed Kim,
Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species.
2012,
Pubmed Kohli,
Label-free quantitative proteomic analysis of the YAP/TAZ interactome.
2014,
Pubmed Koshikawa,
Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
2005,
Pubmed Krall,
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
2010,
Pubmed Kriz,
The podocyte's response to stress: the enigma of foot process effacement.
2013,
Pubmed Kuwahara,
TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.
2006,
Pubmed Lepage,
Identification of two domains involved in the assembly of transient receptor potential canonical channels.
2006,
Pubmed Leuner,
Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
2007,
Pubmed Liu,
High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species.
2013,
Pubmed Liu,
The activation of extracellular signal-regulated kinase is responsible for podocyte injury.
2010,
Pubmed Liu,
The change of spatial cognition ability in depression rat model and the possible association with down-regulated protein expression of TRPC6.
2015,
Pubmed Maier,
Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels.
2015,
Pubmed Miller,
Linear motif atlas for phosphorylation-dependent signaling.
2008,
Pubmed Möller,
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease.
2007,
Pubmed Mottl,
A novel TRPC6 mutation in a family with podocytopathy and clinical variability.
2013,
Pubmed Nijenhuis,
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
2011,
Pubmed Nilius,
Transient receptor potential cation channels in disease.
2007,
Pubmed Nishida,
Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
2010,
Pubmed Onohara,
TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
2006,
Pubmed Pavenstädt,
Cell biology of the glomerular podocyte.
2003,
Pubmed Rappsilber,
Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.
2007,
Pubmed Reiser,
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.
2005,
Pubmed Rinschen,
Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier.
2014,
Pubmed Rinschen,
Comparative phosphoproteomic analysis of mammalian glomeruli reveals conserved podocin C-terminal phosphorylation as a determinant of slit diaphragm complex architecture.
2015,
Pubmed Rinschen,
The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes.
2016,
Pubmed Sakai,
Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy.
2005,
Pubmed Schindl,
The first ankyrin-like repeat is the minimum indispensable key structure for functional assembly of homo- and heteromeric TRPC4/TRPC5 channels.
2008,
Pubmed Seo,
Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy.
2014,
Pubmed Shankland,
The podocyte's response to injury: role in proteinuria and glomerulosclerosis.
2006,
Pubmed Shi,
TRPC6 channels stimulated by angiotensin II are inhibited by TRPC1/C5 channel activity through a Ca2+- and PKC-dependent mechanism in native vascular myocytes.
2010,
Pubmed Sonneveld,
Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
2014,
Pubmed Stambe,
Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis.
2003,
Pubmed Taniguchi,
Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes.
2012,
Pubmed Taus,
Universal and confident phosphorylation site localization using phosphoRS.
2011,
Pubmed Vizcaíno,
ProteomeXchange provides globally coordinated proteomics data submission and dissemination.
2014,
Pubmed Vizcaíno,
2016 update of the PRIDE database and its related tools.
2016,
Pubmed Wang,
Gq signaling causes glomerular injury by activating TRPC6.
2015,
Pubmed Washburn,
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore.
2013,
Pubmed Wedel,
A calmodulin/inositol 1,4,5-trisphosphate (IP3) receptor-binding region targets TRPC3 to the plasma membrane in a calmodulin/IP3 receptor-independent process.
2003,
Pubmed Winn,
Unexpected role of TRPC6 channel in familial nephrotic syndrome: does it have clinical implications?
2006,
Pubmed Winn,
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.
2005,
Pubmed Xue,
GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy.
2008,
Pubmed Zhang,
TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation.
2009,
Pubmed
